These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36271137)

  • 41. The correlation between AMH and number of embryos in POSEIDON groups: a retrospective cohort study.
    Tian H; Mao X; Su N; La X
    Reprod Biomed Online; 2021 Apr; 42(4):842-848. PubMed ID: 33736991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Co-Administration of Clomiphene Citrate and Letrozole in Mild Ovarian Stimulation Versus Conventional Controlled Ovarian Stimulation Among POSEIDON Group 4 Patients.
    Lin HT; Wu MH; Tsai LC; Chen TS; Ou HT
    Front Endocrinol (Lausanne); 2021; 12():780392. PubMed ID: 35095758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of age and antimullerian hormone in assisted reproductive technology program outcome.
    Himabindu Y; Gopinathan KK; Pandey AK; Sriharibabu M
    Indian J Physiol Pharmacol; 2013; 57(1):9-15. PubMed ID: 24020093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle].
    Zhang XR; Ding LL; Tang R; Sheng Y; Qin YY; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):180-5. PubMed ID: 27030496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of hypogonadotropic hypogonadism on ovarian reserve and response.
    Cecchino GN; Canillas GM; Cruz M; García-Velasco JA
    J Assist Reprod Genet; 2019 Nov; 36(11):2379-2384. PubMed ID: 31625035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Value of anti-Müllerian hormone and age in predicting pregnancy outcomes of in vitro fertilization and embryo transfer treatment].
    Chen YH; Wang Q; Zhang YN; Xu XH; Lu J; Zhang SD; Zhang CL
    Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):239-244. PubMed ID: 31006189
    [No Abstract]   [Full Text] [Related]  

  • 47. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
    Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
    Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-Müllerian hormone and antral follicle count differ in their ability to predict cumulative treatment outcomes of the first complete ovarian stimulation cycle in patients from POSEIDON groups 3 and 4.
    Liu L; Zhou C
    J Obstet Gynaecol Res; 2020 Sep; 46(9):1801-1808. PubMed ID: 32686313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?
    Patrelli TS; Gizzo S; Sianesi N; Levati L; Pezzuto A; Ferrari B; Bacchi Modena A
    PLoS One; 2012; 7(9):e44571. PubMed ID: 22984527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Effect of Growth Hormone on the Clinical Outcomes of Poor Ovarian Reserve Patients Undergoing
    Cai MH; Gao LZ; Liang XY; Fang C; Wu YQ; Yang X
    Front Endocrinol (Lausanne); 2019; 10():775. PubMed ID: 31781042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age, body weight and ovarian function affect oocyte size and morphology in non-PCOS patients undergoing intracytoplasmic sperm injection (ICSI).
    Weghofer A; Kushnir VA; Darmon SK; Jafri H; Lazzaroni-Tealdi E; Zhang L; Albertini DF; Barad DH; Gleicher N
    PLoS One; 2019; 14(10):e0222390. PubMed ID: 31647816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of factors associated with ovarian reserve in a group of poor responders to in vitro fertilization: A cross-sectional study.
    Wiweko B; Afdi QF; Harzif AK; Pratama G; Sumapradja K; Muharam R; Hestiantoro A; Zakirah SC
    Int J Reprod Biomed; 2020 Dec; 18(12):1065-1072. PubMed ID: 33426417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle.
    Lin PY; Huang FJ; Kung FT; Chiang HJ; Lin YJ; Lin YC; Lan KC
    Int J Clin Exp Pathol; 2014; 7(9):6245-53. PubMed ID: 25337276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cumulative live-birth, perinatal and obstetric outcomes for POSEIDON groups after IVF/ICSI cycles: a single-center retrospective study.
    Abdullah RK; Liu N; Zhao Y; Shuang Y; Shen Z; Zeng H; Wu J
    Sci Rep; 2020 Jul; 10(1):11822. PubMed ID: 32678263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment.
    Peuranpää P; Hautamäki H; Halttunen-Nieminen M; Hydén-Granskog C; Tiitinen A
    Hum Reprod; 2020 Mar; 35(3):504-515. PubMed ID: 32219343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Associations of FSHR and LHCGR gene variants with ovarian reserve and clinical pregnancy rates.
    Guo C; Yu H; Feng G; Lv Q; Liu X; Liu X
    Reprod Biomed Online; 2021 Sep; 43(3):561-569. PubMed ID: 34391684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ovarian Endometrioma Negatively Impacts Oocyte Quality and Quantity But Not Pregnancy Outcomes in Women Undergoing IVF/ICSI Treatment: A Retrospective Cohort Study.
    Wu Y; Yang R; Lan J; Lin H; Jiao X; Zhang Q
    Front Endocrinol (Lausanne); 2021; 12():739228. PubMed ID: 34880831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome.
    Humaidan P; Alviggi C; Fischer R; Esteves SC
    F1000Res; 2016; 5():2911. PubMed ID: 28232864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.